Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kalela

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Preventive Medicine|May 5, 2009
Hematocrit and the risk of coronary heart disease mortality in the TAMRISK study, a 28-year follow-upT Kunnas, T Solakivi, K Huuskonen, et al.
European Journal of Clinical Investigation|April 16, 2002
Matrix metalloproteinase-9 is elevated in serum of alcohol abusersP Sillanaukee, A Kalela, K Seppä, et al.
European Journal of Biochemistry|January 15, 1998
Characterization of a nuclear localization signal of canine parvovirus capsid proteinsM Vihinen-Ranta, L Kakkola, A Kalela, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 9, 2006
Serum matrix metalloproteinase-9 and venous bypass graft occlusionA Kalela, V Limnell, J Aittoniemi, et al.
Journal of Virology|January 7, 1998
Intracellular route of canine parvovirus entryM Vihinen-Ranta, A Kalela, P Mäkinen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 30, 2004
Serum matrix metalloproteinase-9 is elevated in men with a history of myocardial infarctionJ Renko, A Kalela, O Jaakkola, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 22, 2002
Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery diseaseA Kalela, T A Koivu, T Sisto, et al.
European Journal of Clinical Investigation|July 17, 2001
Serum homocysteine does not associate with uncomplicated coronary heart diseaseS T Nikkari, A Kalela, T A Koivu, et al.
European Journal of Clinical Investigation|January 29, 2000
Association of serum sialic acid and MMP-9 with lipids and inflammatory markersA Kalela, M Pönniö, T A Koivu, et al.
Atherosclerosis|January 5, 2002
Association of serum MMP-9 with autoantibodies against oxidized LDLA Kalela, T A Koivu, M Höyhtyä, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Preventive Medicine|May 5, 2009
Hematocrit and the risk of coronary heart disease mortality in the TAMRISK study, a 28-year follow-upT Kunnas, T Solakivi, K Huuskonen, et al.
European Journal of Clinical Investigation|April 16, 2002
Matrix metalloproteinase-9 is elevated in serum of alcohol abusersP Sillanaukee, A Kalela, K Seppä, et al.
European Journal of Biochemistry|January 15, 1998
Characterization of a nuclear localization signal of canine parvovirus capsid proteinsM Vihinen-Ranta, L Kakkola, A Kalela, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 9, 2006
Serum matrix metalloproteinase-9 and venous bypass graft occlusionA Kalela, V Limnell, J Aittoniemi, et al.
Journal of Virology|January 7, 1998
Intracellular route of canine parvovirus entryM Vihinen-Ranta, A Kalela, P Mäkinen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 30, 2004
Serum matrix metalloproteinase-9 is elevated in men with a history of myocardial infarctionJ Renko, A Kalela, O Jaakkola, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 22, 2002
Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery diseaseA Kalela, T A Koivu, T Sisto, et al.
European Journal of Clinical Investigation|July 17, 2001
Serum homocysteine does not associate with uncomplicated coronary heart diseaseS T Nikkari, A Kalela, T A Koivu, et al.
European Journal of Clinical Investigation|January 29, 2000
Association of serum sialic acid and MMP-9 with lipids and inflammatory markersA Kalela, M Pönniö, T A Koivu, et al.
Atherosclerosis|January 5, 2002
Association of serum MMP-9 with autoantibodies against oxidized LDLA Kalela, T A Koivu, M Höyhtyä, et al.
Pageof 2